EPCAM-targeted CAR-T cells / Sinobioway - LARVOL DELTA

EECSC: Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer (clinicaltrials.gov) - P=N/A; N=19; Suspended; Sponsor: Sinobioway Cell Therapy Co., Ltd.; Phase classification: P1/2 ➔ P=N/A; Recruiting ➔ Suspended; Trial primary completion date: Oct 2016 ➔ Nov 2019

Phase classification • Trial primary completion date • Trial suspension